During the past decade, TTS Research conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 7 clinical trials were completed, i.e. on average, 87.5% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "TTS Research" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Sunovion" with 4 trials sponsored, "Société des Produits Nestlé (SPN)" with 2 trials sponsored, "Amneal Ireland Limited" with 1 trials sponsored and "Bond Avillion 2 Development LP" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "TTS Research" #1 collaborator was "Iqvia Pty Ltd" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "TTS Research" are "Asthma" (7 trials), "Chronic Rhinosinusitis" (2 trials), "Food Hypersensitivity" (2 trials), "Nasal Polyps" (2 trials) and "Perennial Allergic Rhinitis" (2 trials). Many other conditions were trialed in "TTS Research" in a lesser frequency.

Most popular intervention types in "TTS Research" are "Drug" (12 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Lebrikizumab" (2 trials), "Omalizumab" (2 trials), "Active Comparator Formula" (1 trials) and "Amino Acid formula" (1 trials). Other intervention names were less common.

The vast majority of trials in "TTS Research" are 15 trials for "All" genders.

Currently, there are NaN active trials in "TTS Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in TTS Research, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in TTS Research, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".